BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/30/2024 9:47:26 AM | Browse: 49 | Download: 169
 |
Received |
|
2024-06-26 04:10 |
 |
Peer-Review Started |
|
2024-06-26 04:10 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-10-10 07:38 |
 |
Revised |
|
2024-10-22 05:43 |
 |
Second Decision |
|
2024-11-15 16:30 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-12-05 07:32 |
 |
Articles in Press |
|
2024-12-05 07:32 |
 |
Publication Fee Transferred |
|
2024-12-05 09:23 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-12-20 00:09 |
 |
Publish the Manuscript Online |
|
2024-12-30 09:47 |
ISSN |
1948-9358 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Endocrinology & Metabolism |
Manuscript Type |
Observational Study |
Article Title |
Clinical significance of Ki-67 in patients with lung adenocarcinoma in situ complicated by type 2 diabetes
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Ke Chen, Ge Wang, Jing-Cheng Hu, Ying-Yi Zhou and Hai-Tao Ma |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Hai-Tao Ma, Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, No. 188 Shizi Road, Suzhou 215000, Jiangsu Province, China. htma_work@163.com |
Key Words |
Ki-67; Type 2 diabetes mellitus; Lung adenocarcinoma in situ; Immunohistochemistry; Prognostic marker |
Core Tip |
Type 2 diabetes mellitus (T2DM) is an independent risk factor for lung cancer and increases mortality risk; Ki-67, a proliferation marker, is highly expressed in lung cancer, especially with T2DM; elevated Ki-67 levels in adenocarcinoma in situ (AIS) patients with T2DM suggest its utility as a screening marker. Hyperglycemia and insulin resistance in T2DM may drive cancer progression via the Ras/MAPK and IGF-1 signaling pathways. Regular monitoring of Ki-67, glycosylated hemoglobin, and lipid levels is essential for early detection and better prognosis in patients with AIS and T2DM. |
Publish Date |
2024-12-30 09:47 |
Citation |
<p>Chen K, Wang G, Hu JC, Zhou YY, Ma HT. Clinical significance of Ki-67 in patients with lung adenocarcinoma in situ complicated by type 2 diabetes. <i>World J Diabetes</i> 2025; 16(2): 98423</p> |
URL |
https://www.wjgnet.com/1948-9358/full/v16/i2/98423.htm |
DOI |
https://dx.doi.org/10.4239/wjd.v16.i2.98423 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345